PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-4.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$7.52B
AUM Growth
+$7.52B
(-19%)
Cap. Flow
-$663M
Cap. Flow
% of AUM
-8.82%
Top 10 Holdings %
Top 10 Hldgs %
42.45%
Holding
173
New
32
Increased
18
Reduced
39
Closed
33
Top Buys
| 1 |
LABP
Landos Biopharma, Inc. Common Stock
LABP
|
$141M |
| 2 |
BridgeBio Pharma
BBIO
|
$64.7M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$55.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$49.5M |
| 5 |
Exact Sciences
EXAS
|
$46.6M |
Top Sells
| 1 |
Novavax
NVAX
|
$116M |
| 2 |
VYNE Therapeutics
VYNE
|
$110M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$95.2M |
| 4 |
Neurocrine Biosciences
NBIX
|
$93.1M |
| 5 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$90.4M |
Sector Composition
| 1 | Healthcare | 84.38% |
| 2 | Financials | 0.28% |
| 3 | Industrials | 0.21% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $595M | 7.53% | 3,474,505 -219,011 | -6% | -$37.5M |
|
|
2
BridgeBio Pharma
BBIO
$9.89B
| $478M | 6.04% | 7,756,928 +1,050,660 | +16% | +$64.7M |
|
|
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
| $357M | 4.51% | 4,849,912 +672,191 | +16% | +$49.5M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $274M | 3.46% | 8,651,785 -514,519 | -6% | -$16.3M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $226M | 2.86% | 22,861,329 -2,250,719 | -9% | -$22.2M |
|
|
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $206M | 2.61% | 5,058,642 -616,069 | -11% | -$25.1M |
|
|
NVTA
7
DELISTED
Invitae Corporation
NVTA
| $205M | 2.59% | 5,360,673 -1,923,793 | -26% | -$73.5M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $189M | 2.39% | 2,050,002 -1,034,040 | -34% | -$95.2M |
|
9
Atea Pharmaceuticals
AVIR
$267M
| $185M | 2.34% | 3,109,224 | – | – |
|
|
VBIV
10
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $171M | 2.16% | 55,042,465 | – | – |
|
|
LABP
11
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $141M | 1.78% | +14,869,915 | New | +$141M |
|
12
Zymeworks
ZYME
$1.12B
| $137M | 1.73% | 4,330,868 +29,869 | +0.7% | +$943K |
|
13
Outset Medical
OM
$247M
| $130M | 1.64% | 2,387,535 -460,287 | -16% | -$25M |
|
14
Rocket Pharmaceuticals
RCKT
$354M
| $127M | 1.61% | 2,867,771 -529,096 | -16% | -$23.5M |
|
15
C4 Therapeutics
CCCC
$185M
| $117M | 1.48% | 3,158,566 | – | – |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $113M | 1.43% | 812,154 -165,411 | -17% | -$23.1M |
|
17
Aldeyra Therapeutics
ALDX
$351M
| $103M | 1.31% | 8,703,879 +2,418,421 | +38% | +$28.7M |
|
18
MeiraGTx Holdings
MGTX
$587M
| $93.4M | 1.18% | 6,933,277 | – | – |
|
|
19
Neurocrine Biosciences
NBIX
$13.8B
| $91.6M | 1.16% | 941,832 -957,383 | -50% | -$93.1M |
|
|
ALBO
20
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $83.2M | 1.05% | 2,360,139 | – | – |
|
21
Travere Therapeutics
TVTX
$1.56B
| $82.4M | 1.04% | 3,298,419 -195,188 | -6% | -$4.87M |
|
|
KRON
22
DELISTED
Kronos Bio
KRON
| $79.7M | 1.01% | 2,780,097 | – | – |
|
23
Solid Biosciences
SLDB
$427M
| $74.2M | 0.94% | 13,412,552 +2,608,695 | +24% | +$14.4M |
|
24
Relay Therapeutics
RLAY
$619M
| $69.8M | 0.88% | 2,018,097 -311,310 | -13% | -$10.8M |
|
25
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $68.6M | 0.87% | 4,697,612 +25,776 | +0.6% | +$377K |
|